LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
24h
Actual
Mínimo
217.51
Máximo
217.99
Recomendaciones | Comprar |
|---|---|
Estimación a 12 meses | -10.28% downside |
By Acuity
58%
42%
147 / 374 Clasificación en Healthcare
By Trading Central
Confianza
Bearish Evidence
18.88 / 19.67 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
14 nov 2025, 12:31 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update
DJ
Leer
14 nov 2025, 12:16 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
DJ
Leer
14 nov 2025, 11:20 UTC
Cidara Shares Nearly Double Premarket on Report of Takeover by Merck
DJ
Leer
14 nov 2025, 11:11 UTC
Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources
DJ
Leer
23 jun 2025, 12:05 UTC
Cidara Shares Soar Premarket After Positive Influenza Trial Results
DJ
Leer
14 nov 2025, 16:30 UTC
Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com
DJ
Leer
14 nov 2025, 13:19 UTC
This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com
DJ
Leer
14 nov 2025, 12:22 UTC
Pharma Sector Becoming Bidding Battlefield -- Market Talk
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 195.33 USD -10.28%
Máximo 221.5 USD
Mínimo 167 USD
De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CIDARA THERAPEUTICS INC Dist en los últimos 3 meses.
By TipRanks
Comprar
8 ratings
4
Comprar
4
Mantener
0
Vender
De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para CIDARA THERAPEUTICS INC Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Bearish Evidence
Recent bearish events outweigh bullish events.
Medio plazo
Strong Bearish Evidence
All events are bearish.
Largo Plazo
Strong Bullish Evidence
All events are bullish.
By Acuity
Noticias sobre sentimiento de mercado
Coyuntura bajista
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
$